Tuesday, February 09, 2016 3:07:13 PM
My perception from reading AF's post and articles is that his view is that he's correct, and that the DCVax-L product is not much better, if any, from a placebo. He also expressed that NWBT designed the Ph III study with an improper endpoint starting out, so the trial is doomed to fail in his opinion. His motivation is to impress that point on investors so they stay away from the stock or sell out and move on if they're in. I don't know if I can agree that his motivation is that his articles bankrupt the company or help the shorts. He prefers to write about them for years to come, they sell headlines. They allow for interesting debates. He's never bored.
My view on the press releases in general, pro and con:
NWBT writes press releases to accentuate their potential positives, whether actual or apparent, real or imagined.
AF writes press releases to accentuate the Company's negatives whether actual or apparent, real or imagined.
Both at times write in speculator fashion. The whole truth I imagine lies somewhere in the middle. It isn't as glowing as NWBT makes it out to be, nor is it as dark as AF makes it out to be.
Conspiracy theories, I disagree with. But, of course they're open to discussion. I try not to partake.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM